| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 158 | |
| #2 | United States | 70 | |
| #3 | WIPO (World Intellectual Property Organization) | 68 | |
| #4 | EPO (European Patent Office) | 53 | |
| #5 | Canada | 45 | |
| #6 | Brazil | 12 | |
| #7 | China | 12 | |
| #8 | Mexico | 11 | |
| #9 | Norway | 11 | |
| #10 | South Africa | 11 | |
| #11 | Israel | 9 | |
| #12 | Republic of Korea | 9 | |
| #13 | New Zealand | 8 | |
| #14 | Poland | 7 | |
| #15 | Australia | 5 | |
| #16 | Iceland | 4 | |
| #17 | Argentina | 3 | |
| #18 | Bulgaria | 3 | |
| #19 | EAPO (Eurasian Patent Organization) | 3 | |
| #20 | Ecuador | 3 | |
| #21 | Hungary | 3 | |
| #22 | Taiwan | 3 | |
| #23 | African Regional Industrial Property Organization | 2 | |
| #24 | Czechia | 2 | |
| #25 | Spain | 2 | |
| #26 | Hong Kong | 2 | |
| #27 | Japan | 2 | |
| #28 | Slovakia | 2 | |
| #29 | Chile | 1 | |
| #30 | African Intellectual Property Organization | 1 | |
| #31 | Ukraine | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology | |
| #4 | Measurement | |
| #5 | Materials and metallurgy | |
| #6 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Peptides | |
| #4 | Medical preparations | |
| #5 | Acyclic or carbocyclic compounds | |
| #6 | Microorganisms | |
| #7 | Analysing materials | |
| #8 | Building materials | |
| #9 | Unspecified technologies | |
| #10 | Fermentation |
| # | Name | Total Patents |
|---|---|---|
| #1 | Davis Jeremy Martin | 61 |
| #2 | Porter John Robert | 54 |
| #3 | Langham Barry John | 54 |
| #4 | Head John Clifford | 51 |
| #5 | Brookings Daniel Christopher | 36 |
| #6 | Popplewell Andrew George | 35 |
| #7 | Bailey Stuart | 32 |
| #8 | Brand Stephen | 32 |
| #9 | Brown Julien Alistair | 28 |
| #10 | Warrellow Graham John | 27 |
| Publication | Filing date | Title |
|---|---|---|
| GB0600315D0 | Biological products | |
| WO2006038001A1 | Aminopyrimidine derivatives as jnk inhibitors | |
| GB0520169D0 | Biological products | |
| GB0518771D0 | Biological products | |
| GB0514779D0 | Biological products | |
| GB0514486D0 | A protein involved in lung cancer | |
| GB0513852D0 | Biological products | |
| GB0512431D0 | A protein involved in cancer | |
| GB0510735D0 | A protein involved in cancer | |
| GB0510089D0 | A protein involved in cancer | |
| GB0509642D0 | Therapeutics agents | |
| GB0508471D0 | Therapeutic agents | |
| GB0507046D0 | Primers | |
| GB0507042D0 | Primers | |
| GB0507047D0 | Primers | |
| GB0507044D0 | Primers | |
| GB0506914D0 | A protein involved in lung cancer | |
| GB0506912D0 | Biological products | |
| GB0506303D0 | A protein involved in epithelial cell-derived cancers | |
| GB0428065D0 | A protein involved in carcinoma |